-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
- Arrowhead Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 120M shares, a 12.2% increase year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 120M shares, a 12.2% increase from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 107M shares, a 1.26% increase from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 105M shares, a 1.62% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)